SCHEMBL22178583

SCHEMBL22178583

c1ccc(-c2ccccc2-c2ccc3c(c2)c2c4c5ccccc5n5c6ccc(-c7ccccc7-c7ccccc7)cc6c(c6c7ccccc7n3c62)c45)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.37
TSPO P30536 2/20 0.35
HTR6 P50406 2/20 0.33
RET P07949 2/20 0.32
ABCG2 Q9UNQ0 1/20 0.32
PTGS2 P35354 1/20 0.32
APP P05067 1/20 0.32
ALOX5 P09917 1/20 0.31
HPGD P15428 3/20 0.31
KDM4E B2RXH2 3/20 0.31
MEN1 O00255 2/20 0.31
MAPT P10636 2/20 0.31
KMT2A Q03164 2/20 0.31
ALDH1A1 P00352 2/20 0.31
MPI P34949 1/20 0.31
RECQL P46063 1/20 0.31
PLEC Q15149 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
CDC25A P30304 1/20 0.31
CDC25C P30307 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24601508 0.91 TSPO (0.37) HSD17B10TSPOHTR6MEN1MAPT
SCHEMBL22178719 0.91 TSPO (0.37) HSD17B10TSPOHTR6MEN1MAPT
SCHEMBL24601509 0.91 HSD17B10 (0.34) HSD17B10TSPOHTR6ALOX5KDM4E
SCHEMBL24601430 0.91 HSD17B10 (0.36) HSD17B10TSPOHTR6RETABCG2
SCHEMBL24601649 0.91 HSD17B10 (0.36) HSD17B10TSPOHTR6RETABCG2
SCHEMBL22178594 0.90 HSD17B10 (0.37) HSD17B10HTR6RETABCG2PTGS2
SCHEMBL22178722 0.89 FLT3 (0.40) HSD17B10TSPORETHPGDKDM4E
SCHEMBL22178510 0.88 TSPO (0.43) HSD17B10TSPOHTR6ALOX5HPGD
SCHEMBL22178499 0.88 TSPO (0.43) HSD17B10TSPOHTR6ALOX5HPGD
SCHEMBL24601658 0.87 TSPO (0.36) HSD17B10TSPOHPGDKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200212315-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, ELECTRONIC DEVICE, AND COMPOUND IDEMITSU KOSAN CO.,LTD. (JP) 2020-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212315-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, ELECTRONIC DEVICE, AND COMPOUND OR10J3, ESR1, NFE2L2 HSD17B10 605/4885TSPO 2329/4885HTR6 4089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.